Copyright Reports & Markets. All rights reserved.

Global Long-acting Contraceptive Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Long-acting Contraceptive Injection Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Progesterone
    • 1.3.3 Progesterone and Estrogen Combination Preparation
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Long-acting Contraceptive Injection Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 18-25 Years Old
    • 1.4.3 26-35 Years Old
    • 1.4.4 36-45 Years Old
    • 1.4.5 ＞45 Years Old
    • 1.4.6 Others
  • 1.5 Global Long-acting Contraceptive Injection Market Size & Forecast
    • 1.5.1 Global Long-acting Contraceptive Injection Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Long-acting Contraceptive Injection Sales Quantity (2019-2030)
    • 1.5.3 Global Long-acting Contraceptive Injection Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Pfizer
    • 2.1.1 Pfizer Details
    • 2.1.2 Pfizer Major Business
    • 2.1.3 Pfizer Long-acting Contraceptive Injection Product and Services
    • 2.1.4 Pfizer Long-acting Contraceptive Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Pfizer Recent Developments/Updates
  • 2.2 Bayer
    • 2.2.1 Bayer Details
    • 2.2.2 Bayer Major Business
    • 2.2.3 Bayer Long-acting Contraceptive Injection Product and Services
    • 2.2.4 Bayer Long-acting Contraceptive Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Bayer Recent Developments/Updates
  • 2.3 Organon
    • 2.3.1 Organon Details
    • 2.3.2 Organon Major Business
    • 2.3.3 Organon Long-acting Contraceptive Injection Product and Services
    • 2.3.4 Organon Long-acting Contraceptive Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Organon Recent Developments/Updates
  • 2.4 Merck & Co. Inc.
    • 2.4.1 Merck & Co. Inc. Details
    • 2.4.2 Merck & Co. Inc. Major Business
    • 2.4.3 Merck & Co. Inc. Long-acting Contraceptive Injection Product and Services
    • 2.4.4 Merck & Co. Inc. Long-acting Contraceptive Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Merck & Co. Inc. Recent Developments/Updates
  • 2.5 Adare Pharma Solutions
    • 2.5.1 Adare Pharma Solutions Details
    • 2.5.2 Adare Pharma Solutions Major Business
    • 2.5.3 Adare Pharma Solutions Long-acting Contraceptive Injection Product and Services
    • 2.5.4 Adare Pharma Solutions Long-acting Contraceptive Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Adare Pharma Solutions Recent Developments/Updates
  • 2.6 Mylan NV
    • 2.6.1 Mylan NV Details
    • 2.6.2 Mylan NV Major Business
    • 2.6.3 Mylan NV Long-acting Contraceptive Injection Product and Services
    • 2.6.4 Mylan NV Long-acting Contraceptive Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Mylan NV Recent Developments/Updates

3 Competitive Environment: Long-acting Contraceptive Injection by Manufacturer

  • 3.1 Global Long-acting Contraceptive Injection Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Long-acting Contraceptive Injection Revenue by Manufacturer (2019-2024)
  • 3.3 Global Long-acting Contraceptive Injection Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Long-acting Contraceptive Injection by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Long-acting Contraceptive Injection Manufacturer Market Share in 2023
    • 3.4.3 Top 6 Long-acting Contraceptive Injection Manufacturer Market Share in 2023
  • 3.5 Long-acting Contraceptive Injection Market: Overall Company Footprint Analysis
    • 3.5.1 Long-acting Contraceptive Injection Market: Region Footprint
    • 3.5.2 Long-acting Contraceptive Injection Market: Company Product Type Footprint
    • 3.5.3 Long-acting Contraceptive Injection Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Long-acting Contraceptive Injection Market Size by Region
    • 4.1.1 Global Long-acting Contraceptive Injection Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Long-acting Contraceptive Injection Consumption Value by Region (2019-2030)
    • 4.1.3 Global Long-acting Contraceptive Injection Average Price by Region (2019-2030)
  • 4.2 North America Long-acting Contraceptive Injection Consumption Value (2019-2030)
  • 4.3 Europe Long-acting Contraceptive Injection Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Long-acting Contraceptive Injection Consumption Value (2019-2030)
  • 4.5 South America Long-acting Contraceptive Injection Consumption Value (2019-2030)
  • 4.6 Middle East & Africa Long-acting Contraceptive Injection Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Long-acting Contraceptive Injection Sales Quantity by Type (2019-2030)
  • 5.2 Global Long-acting Contraceptive Injection Consumption Value by Type (2019-2030)
  • 5.3 Global Long-acting Contraceptive Injection Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Long-acting Contraceptive Injection Sales Quantity by Application (2019-2030)
  • 6.2 Global Long-acting Contraceptive Injection Consumption Value by Application (2019-2030)
  • 6.3 Global Long-acting Contraceptive Injection Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Long-acting Contraceptive Injection Sales Quantity by Type (2019-2030)
  • 7.2 North America Long-acting Contraceptive Injection Sales Quantity by Application (2019-2030)
  • 7.3 North America Long-acting Contraceptive Injection Market Size by Country
    • 7.3.1 North America Long-acting Contraceptive Injection Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Long-acting Contraceptive Injection Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Long-acting Contraceptive Injection Sales Quantity by Type (2019-2030)
  • 8.2 Europe Long-acting Contraceptive Injection Sales Quantity by Application (2019-2030)
  • 8.3 Europe Long-acting Contraceptive Injection Market Size by Country
    • 8.3.1 Europe Long-acting Contraceptive Injection Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Long-acting Contraceptive Injection Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Long-acting Contraceptive Injection Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Long-acting Contraceptive Injection Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Long-acting Contraceptive Injection Market Size by Region
    • 9.3.1 Asia-Pacific Long-acting Contraceptive Injection Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Long-acting Contraceptive Injection Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Long-acting Contraceptive Injection Sales Quantity by Type (2019-2030)
  • 10.2 South America Long-acting Contraceptive Injection Sales Quantity by Application (2019-2030)
  • 10.3 South America Long-acting Contraceptive Injection Market Size by Country
    • 10.3.1 South America Long-acting Contraceptive Injection Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Long-acting Contraceptive Injection Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Long-acting Contraceptive Injection Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Long-acting Contraceptive Injection Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Long-acting Contraceptive Injection Market Size by Country
    • 11.3.1 Middle East & Africa Long-acting Contraceptive Injection Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Long-acting Contraceptive Injection Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Long-acting Contraceptive Injection Market Drivers
  • 12.2 Long-acting Contraceptive Injection Market Restraints
  • 12.3 Long-acting Contraceptive Injection Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Long-acting Contraceptive Injection and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Long-acting Contraceptive Injection
  • 13.3 Long-acting Contraceptive Injection Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Long-acting Contraceptive Injection Typical Distributors
  • 14.3 Long-acting Contraceptive Injection Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Long-acting Contraceptive Injection market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Long-acting Contraceptive Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Long-acting Contraceptive Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
    Global Long-acting Contraceptive Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
    Global Long-acting Contraceptive Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
    Global Long-acting Contraceptive Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Long-acting Contraceptive Injection
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Long-acting Contraceptive Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Bayer, Organon, Merck & Co. Inc., Adare Pharma Solutions, Mylan NV, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Long-acting Contraceptive Injection market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Progesterone
    Progesterone and Estrogen Combination Preparation
    Market segment by Application
    18-25 Years Old
    26-35 Years Old
    36-45 Years Old
    ＞45 Years Old
    Others
    Major players covered
    Pfizer
    Bayer
    Organon
    Merck & Co. Inc.
    Adare Pharma Solutions
    Mylan NV
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Long-acting Contraceptive Injection product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Long-acting Contraceptive Injection, with price, sales quantity, revenue, and global market share of Long-acting Contraceptive Injection from 2019 to 2024.
    Chapter 3, the Long-acting Contraceptive Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Long-acting Contraceptive Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Long-acting Contraceptive Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Long-acting Contraceptive Injection.
    Chapter 14 and 15, to describe Long-acting Contraceptive Injection sales channel, distributors, customers, research findings and conclusion.

    Buy now